FDA wants data supporting Leronlimab's efficacy. They already know its safety record. We should have what they want in a couple of weeks plus or minus. IMO they are trying not to let the Leronlimab story get ahead of the science and trial results. Very understandable, but if early trial and lab results (3-5 days) show efficacy, there is an ethical dilemma in not publicly announcing and approving Leronlimab treatment.